Harvard Heart Letter

Slow adoption of helpful heart failure drug

Studies have shown that people with heart failure can benefit from the drug spironolactone, but concerns about possible side effects may have made some doctors reluctant to prescribe it.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In